↓ Direkt till sidans innehåll
↓ Direkt till sidans sekundära innehåll (sidomenyn)

Träfflista för sökning "WFRF:(Cassimjee S) "

Search: WFRF:(Cassimjee S)

Result 1-10 of 10

Sort/group result

Sort by: Hits per page:

Enumeration	Reference	Cover	Find
1.	Corbalan, R, et al. (author) Analysis of Outcomes in Ischemic vs Nonischemic Cardiomyopathy in Patients With Atrial Fibrillation: A Report From the GARFIELD-AF Registry 2019 In: JAMA cardiology. - : American Medical Association (AMA). - 2380-6591 .- 2380-6583. ; 4:6, s. 526-548 Journal article (peer-reviewed)
2.	Jukema, JW, et al. (author) Alirocumab in Patients With Polyvascular Disease and Recent Acute Coronary Syndrome: ODYSSEY OUTCOMES Trial 2019 In: Journal of the American College of Cardiology. - : Elsevier BV. - 1558-3597 .- 0735-1097. ; 74:9, s. 1167-1176 Journal article (peer-reviewed)
3.	Ray, KK, et al. (author) Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial 2019 In: The lancet. Diabetes & endocrinology. - 2213-8595 .- 2213-8587. ; 7:8, s. 618-628 Journal article (peer-reviewed)
4.	Roe, MT, et al. (author) Risk Categorization Using New American College of Cardiology/American Heart Association Guidelines for Cholesterol Management and Its Relation to Alirocumab Treatment Following Acute Coronary Syndromes 2019 In: Circulation. - : Ovid Technologies (Wolters Kluwer Health). - 1524-4539 .- 0009-7322. ; 140:19, s. 1578-1589 Journal article (peer-reviewed)
5.	Szarek, M, et al. (author) Alirocumab Reduces Total Hospitalizations and Increases Days Alive and Out of Hospital in the ODYSSEY OUTCOMES Trial 2019 In: Circulation. Cardiovascular quality and outcomes. - : Ovid Technologies (Wolters Kluwer Health). - 1941-7705 .- 1941-7713. ; 12:11, s. e005858- Journal article (peer-reviewed)
6.	Szarek, M, et al. (author) Alirocumab Reduces Total Nonfatal Cardiovascular and Fatal Events: The ODYSSEY OUTCOMES Trial 2019 In: Journal of the American College of Cardiology. - : Elsevier BV. - 1558-3597 .- 0735-1097. ; 73:4, s. 387-396 Journal article (peer-reviewed)
7.	Bittner, VA, et al. (author) Effect of Alirocumab on Lipoprotein(a) and Cardiovascular Risk After Acute Coronary Syndrome 2020 In: Journal of the American College of Cardiology. - : Elsevier BV. - 1558-3597 .- 0735-1097. ; 75:2, s. 133-144 Journal article (peer-reviewed)
8.	Goodman, SG, et al. (author) Effects of Alirocumab on Cardiovascular Events After Coronary Bypass Surgery 2019 In: Journal of the American College of Cardiology. - : Elsevier BV. - 1558-3597 .- 0735-1097. ; 74:9, s. 1177-1186 Journal article (peer-reviewed)
9.	Schwartz, GG, et al. (author) Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome 2018 In: The New England journal of medicine. - : MASSACHUSETTS MEDICAL SOC. - 1533-4406 .- 0028-4793. ; 379:22, s. 2097-2107 Journal article (peer-reviewed)
10.	Cassimjee, Karim Engelmark, et al. (author) Streamlined Preparation of Immobilized Candida antarctica Lipase B 2017 In: ACS Omega. - : American Chemical Society (ACS). - 2470-1343. ; 2:12, s. 8674-8677 Journal article (peer-reviewed)abstract Candida antarctica lipase B (CalB) was efficiently expressed (6.2 g L-1) in Escherichia coli by utilizing an N-terminal tag cassette and the XylS/Pm expression system in a fed-batch bioreactor; subsequent direct binding to EziG from crude extracts resulted in an immobilized catalyst with superior activity to Novozym 435.

Skapa referenser, mejla, bekava och länka

Permalink

Result 1-10 of 10

Refine your search

Type of publication: journal article (10)

Type of content: peer-reviewed (10)

Author/Editor: Nikolaev, K. (9); Davies, R (9); Ito, K. (9); King, M. (8); Li, Y. (8); Schmidt, E. (8); show more...; Zaman, A. (8); Zhang, Z. (8); Zhu, H. (8); Guo, Y (8); Ahmed, H. (8); Kaiser, S. (8); Schwartz, M. (8); Kumar, A. (8); Robinson, S. (8); Zheng, Y. (8); Costa, F. (8); Das, S. (8); Diaz, R. (8); Mahajan, A. (8); Aggarwal, R. (8); Andersen, K (8); Diaz, A. (8); Cohen, S. (8); Rosenberg, M. (8); Gullestad, L (8); Hong, T. (8); Kumar, P. (8); Khan, A. (8); Davis, W. (8); Aboyans, V (8); Khan, M (8); Liu, SW (8); Pandey, A (8); Sarkar, D. (8); Hoffman, D (8); Takahashi, T. (8); Marx, R. (8); Bottcher, M. (8); White, M. (8); Seferovic, P (8); Wells, T (8); Katz, A. (8); Kobayashi-, J (8); Anderson, J. (8); Harding, S (8); Huang, L. (8); Vulic, D (8); Pearce, S (8); Gerber, J. (8); show less...

University: Karolinska Institutet (9); Uppsala University (8); Royal Institute of Technology (1); Lund University (1)

Language: English (10)

Research subject (UKÄ/SCB): Medical and Health Sciences (8); Natural sciences (1)

Year

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

Copyright © LIBRIS - National Library Systems
LIBRIS.kb.se

pil uppåt

Close

Copy and save the link in order to return to this view